Previous studies suggest that not only ER is the the most effective predictor of the response of patients with breast cancer to endocrine therapy but also the extranuclear function of ER cells plays an important role in cell proliferation, movement, and metastasis [13]. The gene discussed is ESR1; the disease is breast carcinoma.